Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome.Annals of hematology · 2024
   Review
2. [The most frequent febrile syndromes and autoinflammatory diseases in adulthood].Zeitschrift fur Rheumatologie · 2024
   Review
3. Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome.Rheumatology advances in practice · 2024
   Article
4. [Autoinflammatory syndromes].Zeitschrift fur Rheumatologie · 2023
   Review
5. [B symptoms in unexplained mediastinal lymphadenopathy : Case report of a 72-year-old male patient with VEXAS syndrome].Innere Medizin (Heidelberg, Germany) · 2023
   Review
6. [Autoinflammatory syndromes].Innere Medizin (Heidelberg, Germany) · 2023
   Article
7. Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.Bone marrow transplantation · 2022
   Review
8. [VEXAS syndrome].Zeitschrift fur Rheumatologie · 2022
   Review
9. Disorders of ubiquitylation: unchained inflammation.Nature reviews. Rheumatology · 2022
   Review
10. Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience.Blood advances · 2022
    Article
11. Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.Frontiers in immunology · 2022
    Observational
12. VEXAS syndrome: An inflammatory and hematologic disease.Seminars in hematology · 2021
    Article

Corrections and comments

• Commented on by
  Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease. Reply.2021
• Comment on
  Somatic Mutations in2020

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as